DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Deeg MA, Buse JB, Goldberg RB, Kendall DM, Zagar AJ, Jacober SJ, Khan MA, Perez AT, Tan MH. on behalf of the GSI.
Pioglitazone and rosiglitazone have different effects on serum lipoprotein particle concentrations and sizes in patients with type 2 diabetes and dyslipidemia.
Diabetes Care 2007; 30: 2458-2464
We do not assume any responsibility for the contents of the web pages of other providers.